hesperidin has been researched along with Myocardial Infarction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; He, J; Li, D; Li, H; Luo, B; Meng, C; Wen, D | 1 |
| Agrawal, YO; Arya, DS; Goyal, SN; Sharma, PK; Shrivastava, B | 1 |
| Ahn, JH; Jung, YS; Park, SW; Yu, HY | 1 |
| Ahmadi Engali, K; Haidari, F; Helli, B; Heybar, H; Jalali, MT; Shirbeigi, E | 1 |
| Balaraman, R; Gandhi, C; Upaganalawar, A | 1 |
1 trial(s) available for hesperidin and Myocardial Infarction
| Article | Year |
|---|---|
Hesperidin supplementation modulates inflammatory responses following myocardial infarction.
Topics: Adipokines; Adiponectin; Adult; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Dietary Supplements; Double-Blind Method; E-Selectin; Female; Hesperidin; Humans; Inflammation; Interleukin-6; Leptin; Male; Middle Aged; Myocardial Infarction; Placebos | 2015 |
4 other study(ies) available for hesperidin and Myocardial Infarction
| Article | Year |
|---|---|
Preventive effect of hesperidin modulates inflammatory responses and antioxidant status following acute myocardial infarction through the expression of PPAR‑γ and Bcl‑2 in model mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; bcl-2-Associated X Protein; Cardiotonic Agents; Caspase 9; Chemokine CCL2; Creatine Kinase, MB Form; Drug Evaluation, Preclinical; Hesperidin; Intercellular Adhesion Molecule-1; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2018 |
Hesperidin blunts streptozotocin-isoproternol induced myocardial toxicity in rats by altering of PPAR-γ receptor.
Topics: Anilides; Animals; Catalase; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Female; Glutathione; Hesperidin; Isoproterenol; L-Lactate Dehydrogenase; Male; Microscopy, Electron, Transmission; Myocardial Infarction; PPAR gamma; Random Allocation; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Troponin I | 2014 |
Preventive effect of yuzu and hesperidin on left ventricular remodeling and dysfunction in rat permanent left anterior descending coronary artery occlusion model.
Topics: Animals; Apoptosis; Blotting, Western; Citrus; Coronary Occlusion; Echocardiography; Enzyme Activation; Hesperidin; Immunohistochemistry; Inflammation; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Peroxidase; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Ventricular Remodeling | 2015 |
Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
Topics: Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Arrhythmias, Cardiac; Biomarkers; Blood Pressure; Catalase; Creatine Kinase, MB Form; Disease Models, Animal; Electrocardiography; Female; Glutathione; Heart Rate; Hesperidin; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitrites; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Ventricular Pressure | 2009 |